Immunology Market: By Drug Class, Fusion Proteins, Immunosuppressants, Polyclonal Antibody, Others), By Indication, By Distribution Channel and Geography  

download arrow download arrow Download Free Sample
settings arrow settings arrow email us

Immunology Market Size, Share, Growth, Trends, and Global Industry Analysis: By Drug Class (Monoclonal Antibodies (mAb), Fusion Proteins , Immunosuppressants, Polyclonal Antibody (pAb), Others), By Indication (Rheumatoid Arthritis, Psoriatic Arthritis, Plaque Psoriasis, Lupus, Ankylosing Spondylitis, Inflammatory Bowel Disease, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Region  

checked icon arrow_drop_down
checked icon Single User License $4400 $3520
checked icon Multiple User License $6600 $5280
checked icon Corporate User License $8900 $7120

Immunology Market size was valued at US$ 93,486.5 million in 2022 and is expected to grow at a significant CAGR of 8.5% from 2023 to 2029. The global market provides a detailed overview of The Immunology Market and and can be segmented by Drug Class, Indication, Distribution Channel. By drug class, the Immunology market has been segmented into Monoclonal Antibodies (mAb), Fusion Proteins, Immunosuppressants, Polyclonal antibodies (pAb), and Others. The monoclonal antibodies segment is likely to be the largest and fastest-growing segment in terms of type. Based on Indication, the immunology market is segmented into Rheumatoid Arthritis, Psoriatic Arthritis, Plaque Psoriasis, Lupus, Ankylosing Spondylitis, Inflammatory Bowel Disease, and Others. Among these, the Rheumatoid Arthritis segment is expected to have the fastest-growing market during the forecast period 2022-2028. Based on Distribution Channel, the immunology market is segmented into Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies. The hospital pharmacies segment accounts for the largest share in 2021. Retail Pharmacies is the second-largest share during the forecast period 2021-2028 according to Precision Business Insights.

Immunology Market Key Developments:
  • In May 2020, AbbVie, Inc. announced the acquisition of Allergan Plc with an aim to expand its presence and strengthen its position in the pharmaceuticals sector across the globe.

summary download arrow Download Free Sample

Immunology Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

8.5%

Largest Market

Asia Pacific

Fastest Growing Market

North America

Immunology Market Dynamics

The increase in the prevalence rate of the different types of cancer and rheumatoid arthritis, rising government initiatives, and increasing funding from the various government and non-government organizations is driving the immunology market.

Immunology Market Segmentation Analysis

Report Benchmarks

Details

Report Study Period

2024-2030

Market Size in 2022

US$ 93,486.5 million

Market CAGR

8.5%

By Drug Class

  • Monoclonal Antibodies (mAb)
  • Fusion Proteins 
  • Immunosuppressants
  • Polyclonal Antibody (pAb)
  • Others

By Indication

  • Rheumatoid Arthritis
  • Psoriatic Arthritis
  • Plaque Psoriasis
  • Lupus
  • Ankylosing Spondylitis
  • Inflammatory Bowel Disease
  • Others

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Key Features of the Report

  • The immunology market report provides granular level information about the market size, regional market share, historic market (2018-2022) and forecast (2023-2029)
  • The report covers in-detail insights about the competitor's overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario

Download Free Sample Report

I accept the Terms and Conditions,Disclaimers, GDPR Policy

Frequently Asked Questions

The immunology market is projected to expand at a CAGR of 8.5% during the forecast period.

Amgen Inc., Novartis AG, Janssen Global Services, LLC, Astellas Pharma inc., UCB SA, Eli Lilly and Company

North America is the fastest-growing region for immunology market

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

1. Executive Summary
2. Global Immunology Market Introduction
2.1. Global Immunology Market - Taxonomy
2.2. Global Immunology Market -Definitions
2.2.1. By Drug Class
2.2.2. By Indication
2.2.3. By Distribution Channel
2.2.4. By Region
3. Global Immunology Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Immunology Market Dynamic Factors - Impact Analysis
3.6. Global Immunology Market - Competition Landscape
4. Global Immunology Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029
4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Immunology Market, By Drug Class, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) 
5.1. Monoclonal Antibodies (mAb)
5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Fusion Proteins
5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Immunosuppressants
5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
5.4. Polyclonal Antibody (pAb)
5.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.3. Market Opportunity Analysis
5.5. Others
5.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.5.3. Market Opportunity Analysis
6. Global Immunology Market, By Indication, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) 
6.1. Rheumatoid Arthritis
6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Psoriatic Arthritis
6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Plaque Psoriasis
6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Lupus
6.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
6.5. Ankylosing Spondylitis
6.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.5.3. Market Opportunity Analysis
6.6. Inflammatory Bowel Disease
6.6.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.6.3. Market Opportunity Analysis
6.7. Others
6.7.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.7.3. Market Opportunity Analysis
7. Global Immunology Market, By Distribution Channel, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) 
7.1. Hospital Pharmacies
7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Retail Pharmacies
7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Online Pharmacies
7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
8. Global Immunology Market Forecast, By Region, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) 
8.1. North America
8.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Europe
8.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Asia-Pacific
8.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
8.4. Latin America
8.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.4.3. Market Opportunity Analysis
8.5. Middle East and Africa
8.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.5.3. Market Opportunity Analysis
8.6. Global Immunology Market - Opportunity Analysis Index, By Drug Class, By Indication, By Distribution Channel, and Region, 2023 - 2029
9. North America Immunology Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) 
9.1. Drug Class Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.1.1. Monoclonal Antibodies (mAb)
9.1.2. Fusion Proteins
9.1.3. Immunosuppressants
9.1.4. Polyclonal Antibody (pAb)
9.1.5. Others
9.2. Indication Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.2.1. Rheumatoid Arthritis
9.2.2. Psoriatic Arthritis
9.2.3. Plaque Psoriasis
9.2.4. Lupus
9.2.5. Ankylosing Spondylitis
9.2.6. Inflammatory Bowel Disease
9.2.7. Others
9.3. Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.3.1. Hospital Pharmacies
9.3.2. Retail Pharmacies
9.3.3. Online Pharmacies
9.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
9.4.1. USA
9.4.2. Canada
9.5. North America Immunology Market - Opportunity Analysis Index, By Drug Class, By Indication, By Distribution Channel, and Country, 2023 - 2029
9.6. North America Immunology Market Dynamics - Trends
10. Europe Immunology Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) 
10.1. Drug Class Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Monoclonal Antibodies (mAb)
10.1.2. Fusion Proteins
10.1.3. Immunosuppressants
10.1.4. Polyclonal Antibody (pAb)
10.1.5. Others
10.2. Indication Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.2.1. Rheumatoid Arthritis
10.2.2. Psoriatic Arthritis
10.2.3. Plaque Psoriasis
10.2.4. Lupus
10.2.5. Ankylosing Spondylitis
10.2.6. Inflammatory Bowel Disease
10.2.7. Others
10.3. Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.3.1. Hospital Pharmacies
10.3.2. Retail Pharmacies
10.3.3. Online Pharmacies
10.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.4.1. Germany
10.4.2. UK
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Russia
10.4.7. Rest of Europe
10.5. Europe Immunology Market - Opportunity Analysis Index, By Drug Class, By Indication, By Distribution Channel, and Country, 2023 - 2029
10.6. Europe Immunology Market Dynamics - Trends
11. Asia-Pacific Immunology Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) 
11.1. Drug Class Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Monoclonal Antibodies (mAb)
11.1.2. Fusion Proteins
11.1.3. Immunosuppressants
11.1.4. Polyclonal Antibody (pAb)
11.1.5. Others
11.2. Indication Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.2.1. Rheumatoid Arthritis
11.2.2. Psoriatic Arthritis
11.2.3. Plaque Psoriasis
11.2.4. Lupus
11.2.5. Ankylosing Spondylitis
11.2.6. Inflammatory Bowel Disease
11.2.7. Others
11.3. Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.3.1. Hospital Pharmacies
11.3.2. Retail Pharmacies
11.3.3. Online Pharmacies
11.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.4.1. China
11.4.2. India
11.4.3. Japan
11.4.4. ASEAN
11.4.5. Australia & New Zealand
11.4.6. Rest of Asia-Pacific
11.5. Asia-Pacific Immunology Market - Opportunity Analysis Index, By Drug Class, By Indication, By Distribution Channel, and Country, 2023 - 2029
11.6. Asia-Pacific Immunology Market Dynamics - Trends
12. Latin America Immunology Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) 
12.1. Drug Class Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Monoclonal Antibodies (mAb)
12.1.2. Fusion Proteins
12.1.3. Immunosuppressants
12.1.4. Polyclonal Antibody (pAb)
12.1.5. Others
12.2. Indication Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.2.1. Rheumatoid Arthritis
12.2.2. Psoriatic Arthritis
12.2.3. Plaque Psoriasis
12.2.4. Lupus
12.2.5. Ankylosing Spondylitis
12.2.6. Inflammatory Bowel Disease
12.2.7. Others
12.3. Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.3.1. Hospital Pharmacies
12.3.2. Retail Pharmacies
12.3.3. Online Pharmacies
12.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Argentina
12.4.4. Rest of Latin America
12.5. Latin America Immunology Market - Opportunity Analysis Index, By Drug Class, By Indication, By Distribution Channel, and Country, 2023 - 2029
12.6. Latin America Immunology Market Dynamics - Trends
13. Middle East and Africa Immunology Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) 
13.1. Drug Class Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1. Monoclonal Antibodies (mAb)
13.1.2. Fusion Proteins
13.1.3. Immunosuppressants
13.1.4. Polyclonal Antibody (pAb)
13.1.5. Others
13.2. Indication Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.2.1. Rheumatoid Arthritis
13.2.2. Psoriatic Arthritis
13.2.3. Plaque Psoriasis
13.2.4. Lupus
13.2.5. Ankylosing Spondylitis
13.2.6. Inflammatory Bowel Disease
13.2.7. Others
13.3. Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.3.1. Hospital Pharmacies
13.3.2. Retail Pharmacies
13.3.3. Online Pharmacies
13.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
13.4.1. Gulf Cooperation Council (GCC) Countries
13.4.2. Israel
13.4.3. South Africa
13.4.4. Rest of MEA
13.5. MEA Immunology Market - Opportunity Analysis Index, By Drug Class, By Indication, By Distribution Channel, and Country, 2023 - 2029
13.6. MEA Immunology Market Dynamics - Trends
14. Competition Landscape 
14.1. Strategic Dashboard of Top Market Players
14.2. Company Profiles (Introduction, Financial Analysis, Offerings, Key Developments, Strategies, and SWOT Analysis)
14.2.1. Pfizer, Inc.
14.2.2. F. Hoffmann-La Roche Ltd.
14.2.3. AbbVie, Inc.
14.2.4. Bristol-Mayers Squibb Company
14.2.5. Merck Sharp & Dohme Corp.
14.2.6. Novartis AG
14.2.7. Janssen Global Services, LLC
14.2.8. Amgen Inc.
14.2.9. Astellas Pharma inc.
14.2.10. UCB SA
14.2.11. Eli Lilly and Company
14.2.12. Allergan plc.
15. Research Methodology
16. Key Assumptions and Acronyms

Key Market Players

  • AbbVie, Inc.
  • Bristol-Mayers Squibb Company
  • Pfizer, Inc.
  • Hoffmann-La Roche Ltd.
  • Allergan plc.
  • Merck Sharp & Dohme Corp.
  • Novartis AG
  • Janssen Global Services, LLC
  • Amgen Inc.
  • Astellas Pharma inc.
  • UCB SA
  • Eli Lilly and Company

Related Industry Reports

Chronic Refractory Gout Pharmaceuticals Market

Familial Mediterranean Fever Pharmaceuticals Market

Australia Point of Care Diagnostics Market

Aseptic Sampling Market